Migraine: Epidemiology, Burden, and Comorbidity

Rebecca C. Burch; Dawn C. Buse; Richard B. Lipton

doi:10.1016/j.ncl.2019.06.001

Migraine: Epidemiology, Burden, and Comorbidity

Rebecca C. Burch, Dawn C. Buse, Richard B. Lipton

Neurology

Research output: Contribution to journal › Review article › peer-review

333 Scopus citations

Abstract

Migraine affects an estimated 12% of the population. Global estimates are higher. Chronic migraine (CM) affects 1% to 2% of the global population. Approximately 2.5% of persons with episodic migraine progress to CM. Several risk factors are associated with the progression to CM. There is significant short-term variability in migraine frequency independent of treatment. Migraine is associated with cardiovascular disease, psychiatric disease, and sleep disorders. It is the second most disabling condition worldwide. CM is associated with higher headache-related disability/impact, medical and psychiatric comorbidities, health care resource use, direct and indirect costs, lower socioeconomic status, and health-related quality of life.

Original language	English (US)
Pages (from-to)	631-649
Number of pages	19
Journal	Neurologic Clinics
Volume	37
Issue number	4
DOIs	https://doi.org/10.1016/j.ncl.2019.06.001
State	Published - Nov 2019

Keywords

Chronic migraine (CM)
Comorbidity
Headache-related disability
Incidence
Migraine
Prevalence
Progression
Risk factors

ASJC Scopus subject areas

Clinical Neurology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ncl.2019.06.001

Cite this

@article{e8123f8f74dd44d2bda6694215a99795,

title = "Migraine: Epidemiology, Burden, and Comorbidity",

abstract = "Migraine affects an estimated 12% of the population. Global estimates are higher. Chronic migraine (CM) affects 1% to 2% of the global population. Approximately 2.5% of persons with episodic migraine progress to CM. Several risk factors are associated with the progression to CM. There is significant short-term variability in migraine frequency independent of treatment. Migraine is associated with cardiovascular disease, psychiatric disease, and sleep disorders. It is the second most disabling condition worldwide. CM is associated with higher headache-related disability/impact, medical and psychiatric comorbidities, health care resource use, direct and indirect costs, lower socioeconomic status, and health-related quality of life.",

keywords = "Chronic migraine (CM), Comorbidity, Headache-related disability, Incidence, Migraine, Prevalence, Progression, Risk factors",

author = "Burch, {Rebecca C.} and Buse, {Dawn C.} and Lipton, {Richard B.}",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",

year = "2019",

month = nov,

doi = "10.1016/j.ncl.2019.06.001",

language = "English (US)",

volume = "37",

pages = "631--649",

journal = "Neurologic Clinics",

issn = "0733-8619",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - Migraine

T2 - Epidemiology, Burden, and Comorbidity

AU - Burch, Rebecca C.

AU - Buse, Dawn C.

AU - Lipton, Richard B.

PY - 2019/11

Y1 - 2019/11

N2 - Migraine affects an estimated 12% of the population. Global estimates are higher. Chronic migraine (CM) affects 1% to 2% of the global population. Approximately 2.5% of persons with episodic migraine progress to CM. Several risk factors are associated with the progression to CM. There is significant short-term variability in migraine frequency independent of treatment. Migraine is associated with cardiovascular disease, psychiatric disease, and sleep disorders. It is the second most disabling condition worldwide. CM is associated with higher headache-related disability/impact, medical and psychiatric comorbidities, health care resource use, direct and indirect costs, lower socioeconomic status, and health-related quality of life.

AB - Migraine affects an estimated 12% of the population. Global estimates are higher. Chronic migraine (CM) affects 1% to 2% of the global population. Approximately 2.5% of persons with episodic migraine progress to CM. Several risk factors are associated with the progression to CM. There is significant short-term variability in migraine frequency independent of treatment. Migraine is associated with cardiovascular disease, psychiatric disease, and sleep disorders. It is the second most disabling condition worldwide. CM is associated with higher headache-related disability/impact, medical and psychiatric comorbidities, health care resource use, direct and indirect costs, lower socioeconomic status, and health-related quality of life.

KW - Chronic migraine (CM)

KW - Comorbidity

KW - Headache-related disability

KW - Incidence

KW - Migraine

KW - Prevalence

KW - Progression

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=85071289596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071289596&partnerID=8YFLogxK

U2 - 10.1016/j.ncl.2019.06.001

DO - 10.1016/j.ncl.2019.06.001

M3 - Review article

C2 - 31563224

AN - SCOPUS:85071289596

SN - 0733-8619

VL - 37

SP - 631

EP - 649

JO - Neurologic Clinics

JF - Neurologic Clinics

IS - 4

ER -

Migraine: Epidemiology, Burden, and Comorbidity

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this